Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Edwards Lifesciences Reports Second Quarter Results
July 24, 2019 6:47 AM EDT
RBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $217.00 (from $186.00) while maintaining an Outperform rating.
Big TAVR Beat; TAVR Market Accelerated In 2Q19...
More
July 24, 2019 6:42 AM EDT
Cowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $210.00) while maintaining a Outperform rating.
The analyst commented, "EW printed a significant 2Q TAVR beat that will reinvigorate investor sentiment ahead of a string of anticipated back-half... More
July 23, 2019 4:18 PM EDT
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.38, $0.05 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.20-$5.40, versus the consensus of $5.29.... More
